Covid-19

Pfizer forecasts $54 billion in revenue in 2022 from sales of its COVID-19 vaccine and antiviral pill alone fueling an expected record of $102 billion

By
1 Mins read
217
0
Share
Reading Time: < 1 minute

Pfizer estimates that it will rake in record-breaking earnings of more than $100 billion this year due to sales of its COVID-19 vaccine and antiviral pill to treat the virus.   Read More

217
0
Share
Related posts
Covid-19

£10bn of taxpayer money wasted on unusable PPE, Covid inquiry finds

By
1 Mins read
Reading Time: < 1 minuteBoris Johnson’s government wasted almost £10bn as it scrambled to buy personal protective equipment (PPE) that was eventually found to be unusable,…
Covid-19

Nigeria: Cross River Identifies 10 More Persons With COVID-19 Symptoms

By
1 Mins read
Reading Time: < 1 minuteThe Cross River State Government said it has identified and isolated 10 persons who interacted with a Chinese national who reimported COVID-19…
Covid-19

New Covid strain that could evade protection from vaccine found in UK

By
1 Mins read
Reading Time: < 1 minuteA new Covid variant spreading across the US has also been identified in the UK, health chiefs have warned. Read More
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.